Guggenheim Securities Downgrades Abbott Laboratories to Neutral

Guggenheim Securities analyst Christopher Pasquale downgrades Abbott Laboratories (NYSE:ABT) from Buy to Neutral.

Benzinga · 01/02/2020 12:17

Guggenheim Securities analyst Christopher Pasquale downgrades Abbott Laboratories (NYSE:ABT) from Buy to Neutral.